Raw material oscillation device for beta-nicotinamide mononucleotide production

Abstract

The utility model discloses a raw material oscillation device for beta-nicotinamide mononucleotide production, and belongs to the technical field of beta-nicotinamide mononucleotide production. The raw material oscillation device for beta-nicotinamide mononucleotide production comprises an oscillation base and an oscillation platform, a fixing plate is arranged in the oscillation base, a driving motor is installed below the fixing plate, the output end of the driving motor is connected with a hexagonal shaft, the hexagonal shaft is sleeved with a rotating disc, and a first wave face is arranged on the lower surface of the rotating disc. According to the raw material oscillation device for beta-nicotinamide mononucleotide production, the driving motor controls the rotating disc to rotate, under the action of the first wave surface, the second wave surface, the first limiting ball and the second limiting ball, vertical vibration and multidirectional inclined superposition are achieved, jolting and swinging composite motion is formed, the actually measured mixing uniformity is improved, and the production efficiency is improved. The wave crest number of the first wave surface is integral multiples of the number of the first limiting balls, so that the vertical vibration synchronism is ensured.

Description

Technical Field

[0001] The utility model relates to the technical field of beta-nicotinamide mononucleotide production, and more specifically, to a raw material oscillating device for producing beta-nicotinamide mononucleotide. Background Art

[0002] β-Nicotinamide mononucleotide (NMN) is an important bioactive substance. Its production process requires that raw materials such as nicotinamide and ribose be thoroughly mixed and reacted at a specific temperature. Traditional oscillating mixing equipment has the following technical defects:

[0003] Uneven mixing: Unidirectional vibration or simple rotation cannot achieve three-dimensional motion, resulting in raw material accumulation or reaction dead corners, affecting product purity;

[0004] Low temperature control accuracy: External heating has slow heat conduction, large temperature fluctuations, and is prone to side reactions;

[0005] Complex structure: Existing three-dimensional oscillation equipment mostly uses multi-motor drive, which is costly and difficult to maintain. Utility Model Content

[0006] The purpose of the present invention is to overcome the deficiencies in the prior art and to provide a raw material oscillating device for the production of β-nicotinamide mononucleotide to solve the above deficiencies.

[0007] In order to achieve the above-mentioned purpose, the technical solution provided by the present utility model is:

[0008] The utility model discloses a raw material oscillating device for producing β-nicotinamide mononucleotide, comprising an oscillating base and an oscillating platform. A fixed plate is provided within the oscillating base, a drive motor is mounted below the fixed plate, an output end of the drive motor is connected to a hexagonal shaft, and the hexagonal shaft is sleeved on a turntable. The lower surface of the turntable is provided with a first wavy surface, and the upper surface of the turntable is provided with a second wavy surface. A first limiting ball in contact with the first wavy surface is provided on the fixed plate, and a second limiting ball in contact with the second wavy surface is provided on the lower surface of the oscillating platform. An extension column is also provided on the lower surface of the turntable, and the extension column is in sliding engagement with the hexagonal shaft.

[0009] Preferably, the number of wave crests / wave troughs of the first wave surface is an integer multiple of the number of the first limiting balls, and the number of wave crests / wave troughs of the second wave surface is a non-integer multiple of the number of the second limiting balls.

[0010] Preferably, a heating block is embedded in the bottom of the oscillation platform, and the lower end of the oscillation platform is sealed with the oscillation base via a rubber sleeve.

[0011] Preferably, a hexagonal hole is provided inside the extension column, which is socketed with the hexagonal shaft. The hexagonal hole can move up and down along the hexagonal shaft, and a support spring is socketed on the extension column. The lower end of the support spring is against the fixed plate.

[0012] Preferably, a positioning ball is provided in the middle of the upper surface of the turntable, and a movable groove matching the positioning ball is provided in the middle of the lower surface of the oscillating platform, and the movable groove allows the oscillating platform to rotate around the positioning ball.

[0013] Preferably, a limit opening is provided on the oscillation base for limiting the vertical movement path of the turntable, and a limit ring is provided on the outer wall of the turntable, and the limit ring is below the limit opening to prevent the turntable from escaping from the limit opening.

[0014] Compared with the prior art, the technical solution provided by this utility model has the following beneficial effects:

[0015] The utility model discloses a raw material oscillating device for producing beta-nicotinamide mononucleotide. A driving motor controls the rotation of a turntable. Under the action of a first wave surface, a second wave surface, a first limiting ball, and a second limiting ball, vertical vibration and multi-directional tilt are superimposed to form a "bumping + swaying" compound motion. The measured mixing uniformity is improved. The number of wave crests on the first wave surface is an integer multiple of the number of the first limiting balls, ensuring the synchronization of the vertical vibration. The number of wave crests on the second wave surface is a non-integer multiple of the number of the second limiting balls, forcing the platform to continuously tilt and change direction. The heating block is directly embedded in the bottom of the oscillating platform, resulting in a short thermal response time and high temperature control accuracy. A single motor drives the vertical and tilting motions simultaneously through a hexagonal shaft, reducing the cost of a multi-motor solution. The limiting opening and the limiting ring constitute an anti-derailment mechanism, reducing the failure rate. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 This is an overall structural diagram of the raw material oscillation device for producing β-nicotinamide mononucleotide of the present utility model;

[0017] Figure 2 This is a partial cross-sectional view of a raw material oscillation device for producing β-nicotinamide mononucleotide according to the present invention;

[0018] Figure 3 This is a diagram of the internal connection structure of the raw material oscillation device for the production of β-nicotinamide mononucleotide of the present utility model;

[0019] Figure 4 This is an exploded first perspective view of the raw material oscillation device for producing β-nicotinamide mononucleotide of the present invention;

[0020] Figure 5 This is a second perspective view of the exploded raw material oscillation device for producing β-nicotinamide mononucleotide of the present invention.

[0021] In the figure: 1. Oscillation base; 11. Fixed plate; 111. First limiting ball; 12. Driving motor; 13. Hexagonal shaft; 14. Limiting opening; 15. Control panel; 2. Oscillation platform; 21. Movable slot; 22. Second limiting ball; 23. Rubber sleeve; 24. Heating block; 3. Turntable; 31. First wave surface; 32. Second wave surface; 33. Extension column; 34. Support spring; 35. Positioning ball; 36. Limiting ring. DETAILED DESCRIPTION

[0022] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the embodiments described are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative efforts are within the scope of protection of the present invention.

[0023] In order to further understand the content of the present invention, the present invention is described in detail with reference to the accompanying drawings.

[0024] Combine Figure 1-Figure 5 The raw material oscillation device for the production of β-nicotinamide mononucleotide of the present invention includes an oscillation base 1 and an oscillation platform 2. A fixed plate 11 is provided in the oscillation base 1, and a driving motor 12 is provided on the lower surface of the fixed plate 11. A hexagonal shaft 13 is provided at the output end of the driving motor 12. A turntable 3 is sleeved on the hexagonal shaft 13. The upper end of the turntable 3 is movably connected to the oscillation platform 2. The hexagonal shaft 13 is driven to rotate by the driving motor 12, and the hexagonal shaft 13 drives the turntable 3 to rotate.

[0025] Specifically, a first wave surface 31 is provided on the lower surface of the turntable 3, and a first limiting ball 111 is provided on the upper surface of the fixed plate 11. The first limiting ball 111 contacts the first wave surface 31. An extension column 33 is provided in the middle position of the lower surface of the turntable 3. A hexagonal hole is provided inside the extension column 33, and the hexagonal hole is socketed with the hexagonal shaft 13. The hexagonal hole can move up and down along the hexagonal shaft 13, and a support spring 34 is socketed on the extension column 33. The lower end of the support spring 34 is against the fixed plate 11. The support spring 34 and the first limiting ball 111 jointly support the height of the turntable 3, and the extension column 33 is driven to rotate by the hexagonal shaft 13. At the same time, the first limiting ball 111 alternately contacts the trough and peak of the first wave surface 31, pushing the turntable 3 to vibrate up and down.

[0026] At the same time, a second wave surface 32 is provided on the upper surface of the turntable 3, and a positioning ball 35 is provided in the middle position of the upper surface of the turntable 3. A movable groove 21 matching the positioning ball 35 is provided in the middle position of the lower surface of the oscillation platform 2. The movable groove 21 allows the oscillation platform 2 to rotate around the positioning ball 35, while meeting the tilting needs of the oscillation platform 2. A second limiting ball 22 in contact with the second wave surface 32 is provided on the lower surface of the oscillation platform 2. When the second wave surface 32 rotates with the turntable 3, the troughs and peaks of the second wave surface 32 push the oscillation platform 2 to tilt.

[0027] It should be noted that the troughs and crests of the first wave surface 31 and the second wave surface 32 appear alternately, and the number of troughs and crests is the same, but the number of troughs or crests of the first wave surface 31 is an integer multiple of the first limiting balls 111. For example, in this embodiment, the number of troughs or crests of the first wave surface 31 is 10, and the number of first limiting balls 111 is 5. In this way, the first limiting balls 111 will be in the troughs or crests of the first wave surface 31 at the same time, and the lower surface of the turntable 3 maintains vertical movement. While the turntable 3 rotates, it moves vertically up and down under the support of the support spring 34. In order to maintain the stability of the up and down movement of the turntable 3, a limiting opening 14 is provided on the oscillation base 1 for limiting the vertical movement path of the turntable 3. A limiting ring 36 is provided on the outer wall of the turntable 3. The limiting ring 36 is below the limiting opening 14 to prevent the turntable 3 from escaping from the limiting opening 14.

[0028] It should also be noted that the number of troughs or crests of the second wave surface 32 is not an integer multiple of the number of second limiting balls 22. For example, the number of second limiting balls 22 is 3 for easy control, and the number of troughs or crests of the second wave surface 32 is still 10. Then, when the second wave surface 32 rotates, one of the second limiting balls 22 contacts the trough, and the other two of the second limiting balls 22 must not be in the trough of the second wave surface 32. On the contrary, they are lifted up by the crests of the second limiting balls 22. The lower surface of the oscillation platform 2 is always tilted, and under the continuous rotation of the second wave surface 32, the oscillation platform 2 continuously changes its tilt direction around the positioning balls 35, and the oscillation platform 2 will also vibrate up and down driven by the turntable 3, thereby improving the vibration effect.

[0029] More specifically, in order to limit the oscillation platform 2 from rotating with the turntable 3, a rubber sleeve 23 is provided at the lower end of the oscillation platform 2, and the lower end of the rubber sleeve 23 is fixedly connected to the upper end of the oscillation base 1. The rubber sleeve 23 allows the oscillation platform 2 to tilt while preventing external foreign matter from entering the interior of the oscillation base 1. A heating block 24 is also provided at the bottom of the oscillation platform 2, and a control panel 15 is provided on the outer wall of the oscillation base 1 for controlling the temperature of the heating block 24 and the operation of the drive motor 12.

[0030] Working process: The raw materials for β-nicotinamide mononucleotide production are placed on the oscillation platform 2. The temperature and speed of the drive motor 12 are set through the control panel 15. The heating block 24 preheats the oscillation platform 2. The temperature sensor feeds real-time data to the control panel 15. The drive motor 12 drives the hexagonal shaft 13 to rotate. At the same time, the first limiting ball 111 contacts the first wave surface 31. The turntable 3 moves up and down through the extension column 33 and support spring 34 to ensure stable vertical vibration. When the turntable 3 rotates, the second wave surface 32 pushes the second limiting ball 22, causing the oscillation platform 2 to tilt at multiple angles around the positioning ball 35. The vertical vibration and the tilt oscillation are superimposed to form a "bump + swing" compound motion in three-dimensional space, which oscillates and mixes the raw materials for β-nicotinamide mononucleotide production evenly.

[0031] It should be noted that, in this document, relational terms such as first and second, etc., are used only to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any actual relationship or order between these entities or operations. Moreover, the terms "comprises," "comprising," or any other variations thereof are intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus that includes a list of elements includes not only those elements but also other elements not explicitly listed, or elements inherent to such process, method, article, or apparatus.

[0032] Although the embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to these embodiments without departing from the principles and spirit of the present invention.

Claims

1. A raw material oscillating device for producing β-nicotinamide mononucleotide, comprising an oscillating base (1) and an oscillating platform (2), characterized in that: The oscillation base (1) is provided with a fixed plate (11), a driving motor (12) is installed below the fixed plate (11), an output end of the driving motor (12) is connected to a hexagonal shaft (13), the hexagonal shaft (13) is sleeved on a turntable (3), a first wave surface (31) is provided on the lower surface of the turntable (3), a second wave surface (32) is provided on the upper surface of the turntable (3), a first limiting ball (111) in contact with the first wave surface (31) is provided on the fixed plate (11), a second limiting ball (22) in contact with the second wave surface (32) is provided on the lower surface of the oscillation platform (2), and an extension column (33) is further provided on the lower surface of the turntable (3), and the extension column (33) is in sliding engagement with the hexagonal shaft (13).

2. The raw material oscillating device for producing β-nicotinamide mononucleotide according to claim 1, characterized in that: The number of wave crests / wave troughs of the first wave surface (31) is an integer multiple of the number of first limiting balls (111), and the number of wave crests / wave troughs of the second wave surface (32) is a non-integer multiple of the number of second limiting balls (22).

3. The raw material oscillating device for producing β-nicotinamide mononucleotide according to claim 1, characterized in that: A heating block (24) is embedded in the bottom of the oscillating platform (2), and the lower end of the oscillating platform (2) is sealedly connected to the oscillating base (1) via a rubber sleeve (23).

4. The raw material oscillating device for producing β-nicotinamide mononucleotide according to claim 1, characterized in that: The extension column (33) is provided with a hexagonal hole inside, the hexagonal hole is sleeved with the hexagonal shaft (13), and a support spring (34) is sleeved on the extension column (33). The extension column (33) is sleeved with the support spring (34).

5. The raw material oscillating device for producing β-nicotinamide mononucleotide according to claim 1, characterized in that: A positioning ball (35) is provided at a middle position on the upper surface of the turntable (3), and a movable groove (21) matching the positioning ball (35) is provided at a middle position on the lower surface of the oscillation platform (2).

6. The raw material oscillating device for producing β-nicotinamide mononucleotide according to claim 1, characterized in that: A limiting opening (14) is provided on the oscillation base (1), and a limiting ring (36) is provided on the outer wall of the turntable (3), wherein the limiting ring (36) is below the limiting opening (14).

Images